Researchers have discovered the presence of common hepatocellular carcinoma (HCC)-associated gene mutations, such as TP53, CTNNB1, and AXIN1, in blood samples from HCC patients [32–34]. This evidence concerns the gene TP53 and hepatocellular carcinoma.